Assessment of PD‐L1 expression and tumor‐infiltrating lymphocytes (TILs) across molecular subtypes of triple‐negative breast cancer.

Authors :: Sood, Ridhi
Kumar, Sandeep
Laroiya, Ishita
Khare, Siddhant
Das, Ashim
Singh, Gurpreet
Bal, Amanjit
Source :: Breast Journal. Dec2020, Vol. 26 Issue 12, p2424-2427. 4p.
Publication Year :: 2020
Abstract: The article offers information about the assessment of PD-L1 expression and tumor-infiltrating lymphocytes (TILs) across molecular subtypes of triplenegative breast cancer. It mentions that triple-negative breast cancers (TNBC) lack actionable targets and show varied responses to chemotherapy influenced by molecular heterogeneity or degree of immune cell (IC) infiltration.

Subjects :: *THERAPEUTIC use of antineoplastic agents
*ANTIGENS
*BIOMARKERS
*BREAST tumors
*GENE expression
*IMMUNOHISTOCHEMISTRY
*LYMPHOCYTES
*TREATMENT effectiveness
*ANDROGEN receptors
*DESCRIPTIVE statistics

Full Text Access

Tools